Skip to content

4th Edition

Milan Colorectal
Congress

May  27-29, 2026

Humanitas Centro Congressi
Via Alessandro Manzoni, 113, Milano, 20072

About Milan Colorectal Congress

We are pleased to present you the 4th edition of the Milan ColoRectal Congress that will take place in Milan, Italy at Humanitas Centro Congressi, Via Alessandro Manzoni, 113 on May 27th- 29th, 2026, organized by Prof. Luigi Boni, Prof. Pierpaolo Sileri and Prof. Antonino Spinelli.

The Congress will represent an important moment of sharing knowledge, also in 2026 it will be focused on colorectal surgery and oncologic treatments, a deep dive in topics like colon and rectal cancer updates and cutting-edge treatments, discussion oncology vs surgery.

Leading authorities in the field of colorectal surgery, forming an international scientific panel, will contribute to an exceptional scientific program through a blend of plenary lectures, sponsored lunch symposia, and live surgeries, ensuring a superior level of engagement.

Congress Presidents

Prof. Antonino Spinelli

Prof. Antonino Spinelli

Humanitas Hospital, Milan

Prof. Luigi Boni

Prof. Luigi Boni

Fondazione IRCCS Ca’ Granda Hospital, Milan

Prof. Pierpaolo Sileri

Prof. Pierpaolo Sileri

San Raffaele Hospital, Milan

Congress structure

Pre and core congress, for personalised training.

The medical congress is organised in two key segments to maximise learning and engagement.

On 27 May, the pre-congress will feature 4 mini-conferences, which will offer in-depth exploration of specific topics.
The Core Congress will be held on 28 and 29 May, which will serve as a main event with in-depth sessions, expert panels and networking opportunities.

This facility ensures a dynamic and enriching experience for all participants.

PRE-CONGRESS

May 27th

There are 4 different pre-congresses scheduled simultaneously. Each participant can select the pre-congress of his interest.

CORE-CONGRESS

May 28th/29th

Main congress to be held in plenary session for all participants 

PRE-CONGRESS AVAIBLE

Robotic TTSS & TAMIS

Humanitas Congress Center

COORDINATOR: Prof. Antonino Spinelli

Lecture course

Limited partecipants 40 pax.

Live Surgery Streaming Symposium on Cutting Edge Technologies in Surgery

Fondazione IRCCS Ca’ Granda Ospedale

COORDINATOR: Prof. Luigi Boni

Live Surgery and lecture. Limited partecipants 30 pax.

Core Management on Anal Fistula

San Raffaele Hospital

COORDINATOR: Prof. Pierpaolo Sileri

Hands on course. Limited partecipants 10 pax.

Robotic Ventral Mesh Rectopexy for Obstructed Defecation Syndrome with Hugo RAS System

San Raffaele Hospital

COORDINATOR: Prof. Pierpaolo Sileri

Live Surgery Course. Limited partecipants 6 pax.

Venue

Core Congress
Location

Humanitas Centro Congressi

Via Alessandro Manzoni, 113, Milano, 20072

With unconditional contribute of

PLATINUM

BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company develops innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD has presence in virtually every country around the world to address some of the most challenging global health issues. BD helps customers enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care.

Medtronic is a global leader in healthcare technology and one of the few companies able to support the entire surgical pathway. With a broad portfolio spanning advanced energy, stapling, robotic-assisted surgery technologies including the Hugo RAS System platform, Medtronic is committed to supporting surgeons in delivering consistent, efficient and patient-centered care. Beyond technology, Medtronic strongly invests in surgical education and clinical training through innovative digital solutions such as Touch Surgery, helping healthcare professionals enhance skills, collaboration and procedural standardization across the surgical community.

GOLD

Intuitive (NASDAQ: ISRG), headquartered in Sunnyvale, California, is a global leader in minimally invasive therapy and a pioneer in robotic surgery. Our technologies include the da Vinci surgical systems and the Ion endoluminal system. Through the integration of advanced systems, progressive training, and value-added services, we support physicians and their teams in optimizing care delivery and achieving the best possible outcomes. At Intuitive, we envision a future of healthcare that is less invasive and profoundly better, where disease is identified early and treated promptly, enabling patients to return to their most important activities and relationships.
Arthrex is a global leader in the field of medical devices for orthopedic surgery, specializing in minimally invasive techniques for sports medicine, arthroscopy, and trauma surgery. Founded in 1981 (and present in Italy since 1985), the company develops over 1,000 new products per year, with the aim of improving patient care through technological innovation and training.
Johnson & Johnson is a global healthcare leader, committed to solving the toughest health challenges and transforming lives through research, development, manufacture and distribution of medicines and medical technologies. The company’s Innovative Medicine business advances breakthrough science and develops transformational treatments in areas like oncology, immunology, neuroscience, and cardiopulmonary. In MedTech, the company is focused on developing and delivering cardiovascular, surgery, and vision solutions. Visit jnj.com to learn more
Movi S.p.A., founded in 1912, is a well-established company in the medical devices sector that connects leading international manufacturers with the Italian healthcare system. Movi distributes high-quality products and cutting-edge services, positioning itself as a trusted reference point for the entire medical community across the country.
Stryker is a global leader in medical technology, making a tangible impact on more than 150 million patients every year.We work alongside healthcare professionals to transform the quality of care and make treatment pathways more effective and efficient.Through a comprehensive portfolio of innovative solutions in the medical-surgical, neurotechnology, and orthopedic fields, we help our customers improve clinical outcomes and generate real value for patients and healthcare facilities.

SILVER

KARL STORZ, a medical technology company founded in 1945 in Tuttlingen, Germany, is an international leader in endoscopic, imaging and integrated operating room solutions across many human and veterinary surgical specialties. Now in its third generation, the family-owned company employs 9,900 people in more than 50 countries worldwide. KARL STORZ stands for visionary design, precision craftsmanship, and clinical effectiveness, including advancements in digital surgery. Sales for the fiscal year 2024 were 2.24 billion euros. Production sites are located in Germany, the USA, Switzerland, Estonia and China.
KARL STORZ SE & Co. KG has been headquartered in Tuttlingen, Baden-Württemberg since 1945 and manufactures instruments and equipment in the medical technology sector. It specializes in endoscopy and minimally invasive surgery.
EndoFresh — A Global Leader in Single-Use GI Endoscopy Solutions Focused on safety and efficiency, EndoFresh delivers accessible, portable GI endoscopy solutions that improve clinical efficiency, reduce infection risks, and support better use of medical resources.
B. Braun Milan offers the Italian healthcare market a comprehensive range of products and systems for hospital care, anesthesia, intensive care, artificial nutrition, infusion therapy, surgery, cardiology, and general medicine, as well as for the outpatient sector with products and services for home care. Founded in 1922, B. Braun Milan is the first of the Group’s international subsidiaries and has since focused on the commercialization and distribution of healthcare solutions. With approximately 250 professionals, the company ensures extensive coverage across the national territory.
The core business of Chiru-med Srl is the sale of medical devices and equipment for laparoscopic, thoracic, bariatric, endoscopic, urogynecological, and robotic surgery, as well as for various other medical and surgical specialties (general and regenerative surgery, ultrasound systems). Its activity is primarily focused on “PRIVATE” customers (groups or private clinics, nursing homes, clinical research centers, outpatient clinics, and medical practices) in Italy and in other European Union countries (Spain, Albania, Sweden, Germany, Czech Republic, Netherlands, Malta).
Lipogems International S.p.A. is an Italian multinational company based in Milan, operating in the biotechnology sector and a leader in regenerative medicine with the Lipogems® system for processing adipose tissue. Lipogems products have undergone rigorous clinical testing and are used globally for the treatment of various conditions, helping to accelerate patient recovery and enabling them to return to normal life.

BASIC

MEDIA PARTNER

Organizal secretariat

Do you need some information?

Materia Prima is the organizing secretariat of the event and is at your disposal for any information.

segreteria@materia1a.it

+39 346868 6989

Frequently Asked Questions

How can I register for the congress?

To register for the congress you will simply click on the “Register now” or “Reserve your place” button and fill the registration form on the dedicated page of the Materia Prima Secretariat. For any questions or information do not hesitate to contact us. 

Of course, the conference attendance is customisable according to your preferences. Each participant can choose the option only congress or pre-congress + congress. The cost of participation is related to the selected participation modalities. For any questions or information do not hesitate to contact us. 

All available pre-congresses will be held simultaneously on 28 May 2025, in a different location, as indicated in the congress page and scientific program. Therefore, it is not possible to attend more than one pre-conference. Please note that there are limited places available for pre-conferences.

Participation costs vary according to participant preferences and type. All details are contained in the registration page hosted on the website of the organizing secretariat Materia Prima. For any information the organizing secretariat is at your disposal from Monday to Friday from 9.00am to 18.00pm to the contacts given above.

The official language of the Congress is English. No simultaneous translation is available.

The event time zone will be in Milan, which corresponds to UTC +1/ Central European Time (CET)

Of course, the certificates of participation in the Congress can be downloaded online, 10 days after the end of the event. An e-mail will be sent to inform all participants of the correct procedure.